<Original Article>The involvement of bradykinin in adrenaline-induced pulmonary edema in rats

概要

論文の詳細を見る
We investigated the effect of endogenous bradykinin on adrenaline-induced pulmonary edema (PE) by blocking bradykinin receptors. In preliminary experiments, a bolus injection of adrenaline (ADR; 10 μg/kg) solution (10 μg/ml) was determined to be an edematogenic dose for inducing PE. The lung body weight index (LBI) and incidence of PE (IPE) were determined. The IPE and LBI of the group pretreated with Des-Arg^9-[Leu^8]-Bradykinin (DA-BK, 50 μg/kg, 50 μg/ml) increased significantly compared with those of the control group (p<0.05). On the other hand, there were no remarkable changes in IPE and LBI in the groups pretreated with Hoe140 (D-Arginyl-[Hyp^3, Thi^5, D-Tic^7, Oic^8]-Bradykinin (100 μg/kg, 100 μg/ml), captopril (20 mg/kg, 20 mg/ml) or L-NAME (1 mg/kg 1 mg/ml). Moreover, the IPE and LBI of the group co-treated with L-NAME and DA-BK decreased compared with the DA-BK group (p<0.05). Thus, bradykinin aggravates adrenaline-induced PE through activation of the B_2 receptor by the kallikreins as a result of the ADR administration, although the precise mechanism is not known.
東京医科歯科大学の論文